Schedule 13D ownership disclosure
NKGEN BIOTECH INC
Common Stock, $0.0001 par value per share · CUSIP: 65488A101
Event date: 2025-05-27
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- CFIC-2015 NV Family Investments, LLCReported CIK 0002034776
Shares: 63,175,321.00 · Class: 47.2%
- Andrew Jin-Chan CherngReported CIK 0002035448
Shares: 63,175,321.00 · Class: 47.2%
- Peggy CherngReported CIK 0001235503
Shares: 63,175,321.00 · Class: 47.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-055326
- Form type
- SCHEDULE 13D
- Filer
- CFIC-2015 NV Family Investments, LLC
- CIK
- CIK 2034776
- Filed
- Jun 02, 2025
- Reporting period
- May 27, 2025
- Description
- Schedule 13D beneficial ownership